Pharmaceutical Excipients Market: By Product (Inorganic Chemicals, Organic Chemicals, Petrochemicals), By Function (Fillers and Diluents, Coatings, Binders, Disintegrants, Flavouring Agents, Colorants), By Dosage Form (Tablets, Capsules, Liquids, Injections), By End User (Biotech Companies, Pharmaceutical Companies, Research Institutes) and Geography    

Purchase Option

$ 4400
$ 6600
$ 8900

Pharmaceutical Excipients Market size was valued USD 6.9 billion in 2022 and is expected to reach USD 10.8 billion by 2028 at a significant CAGR of 6.1% from 2023-2029. Pharmaceutical excipients are combined with active pharmaceutical ingredients to produce the final dosage form of the drugs. The excipients provide bulkiness to formulation, facilitates absorption of the drug, provides stability and prevent from the drugs from denaturation. pharmaceutical excipients market are cost effective, stable, feasible for handling, and inert in the nature. The excipient is a material that has been tested for safety and is added to a medication delivery system. It is not an active pharmaceutical ingredient (API). The main functions of excipients are to protect, support, improve stability, bioavailability, patient acceptability, and aid in effectiveness. The market is made up of sales of pharmaceutical excipients and revenue earned by the company's manufacturing of these excipients. The major advantages of using excipients are improving property of wetting, increase bulkiness of drug, provides stability, and improves the organoleptic properties of the drug. Excipients are used in a different medicinal products like capsules, tablets, oral liquids, inhalers, implants and injections among others. Factors such as patient compliance and ease in consumption forcing drug manufactures in developing a sustained release dosage formulations which contributes to the extension of shelf life of the oral drugs that adds to the high revenue anticipation of pharmaceutical excipients. However, lack of standard quality policies and regulations for excipients and safety evaluation is expected to hamper the growth of the market over the forecast period.

Pharmaceutical Excipients Market Key Developments:

  • In June 2017, Ashland Inc. got US patent for purekote 23589 (dispersion) and purekote 21412a (cross linking agent) coating system.
  • In April 2017, Lubrizol Corporations Skin Essentials division launched new acrylate-based polymeric emulsifier Pemulen EZ-4U.
  • In July 2016, The Lubrizol Corporation acquired Diamond Dispersions Ltd to expand its product portfolio that enable digital painting.

Global Pharmaceutical Excipients Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

6.1%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Pharmaceutical Excipients Market Dynamics

Global pharmaceutical excipients market is driven by growing demand for oral pharmaceuticals (solid) and development of novel therapeutics because of increase in pharmaceutical industries. The combination of nanotechnology and drug formulations in excipients led the development of nano-derived liposomes, vaccines, and nano coated tablets. The global pharmaceutical excipients market is expected to grow at a significant CAGR over the forecast period owing to increase in utilization of parenteral products, rise in the global burden of chronic & lifestyle diseases and increasing investments by the pharmaceutical industry on the development of biologics. Good manufacturing and distribution practices for for uniform excipients, spanning regions by international regulatory authorities is set to define the market landscape of the excipient industry over the forecast period.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Global Pharmaceutical Excipients Market Segmentation

By Product Type
  • Inorganic Chemicals
  • Organic Chemicals
  • Petrochemicals
By Function
  • Fillers and Diluents
  • Coatings
  • Binders
  • Disintegrants
  • Flavouring Agents
  • Colorants
  • Others
By Dosage Form
  • Tablets
  • Capsules
  • Liquids
  • Injections
  • Others
By End User
  • Biotech Companies
  • Pharmaceutical Companies
  • Research Institutes
By Geography
  • North America
  • Latin America
  • Europe
  • Asia-Pacific
  • Middle East & Africa

Frequently Asked Questions

The key segments covered in the pharmaceutical excipients market are technology, components, application, and end-users.

The Pharmaceutical excipients market size was valued at USD 6.9 billion in 2022.

The Pharmaceutical excipients market key players are Ashland Inc.(U.S.), AkzoNobel (Netherlands), The DOW Chemical Company (U.S.), Archer Daniels Midland Company(U.S.), Associated British Foods PLC (UK), Colorcon, Inc.(U.S.), BASF SE(Germany), Evonik Industries AG (Germany), Innophos Holdings Inc. (U.S.), J.M. Huber Corporation (U.S.), FMC Corporation (U.S.), Roquette Group (Nord-Pas de Calais), Croda International PLC (UK), Merck KGaA (U.S.), Lubrizol Corporation (U.S.)

1.Executive Summary
2.Global Pharmaceutical Excipients Market Introduction 
2.1.Global Pharmaceutical Excipients Market  - Taxonomy
2.2.Global Pharmaceutical Excipients Market  - Definitions
2.2.1.Product Type
2.2.2.Function
2.2.3.Dosage Form
2.2.4.End User
2.2.5.Region
3.Global Pharmaceutical Excipients Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Pharmaceutical Excipients Market Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Pharmaceutical Excipients Market  By Product Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. Inorganic Chemicals
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Organic Chemicals
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Petrochemicals
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6.Global Pharmaceutical Excipients Market  By Function, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. Fillers and Diluents
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Coatings
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Binders
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Disintegrants
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Flavouring Agents
6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
6.6. Colorants
6.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.6.3. Market Opportunity Analysis 
6.7. Others
6.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.7.3. Market Opportunity Analysis 
7.Global Pharmaceutical Excipients Market  By Dosage Form, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. Tablets
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Capsules
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Liquids
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Injections
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Others
7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8.Global Pharmaceutical Excipients Market  By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. Biotech Companies
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Pharmaceutical Companies
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Research Institutes
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
9.Global Pharmaceutical Excipients Market  By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10.North America Pharmaceutical Excipients Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Inorganic Chemicals
10.1.2.Organic Chemicals
10.1.3.Petrochemicals
10.2.  Function Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Fillers and Diluents
10.2.2.Coatings
10.2.3.Binders
10.2.4.Disintegrants
10.2.5.Flavouring Agents
10.2.6.Colorants
10.2.7.Others
10.3.  Dosage Form Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Tablets
10.3.2.Capsules
10.3.3.Liquids
10.3.4.Injections
10.3.5.Others
10.4.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Biotech Companies
10.4.2.Pharmaceutical Companies
10.4.3.Research Institutes
10.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11.Europe Pharmaceutical Excipients Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
11.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Inorganic Chemicals
11.1.2.Organic Chemicals
11.1.3.Petrochemicals
11.2.  Function Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Fillers and Diluents
11.2.2.Coatings
11.2.3.Binders
11.2.4.Disintegrants
11.2.5.Flavouring Agents
11.2.6.Colorants
11.2.7.Others
11.3.  Dosage Form Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Tablets
11.3.2.Capsules
11.3.3.Liquids
11.3.4.Injections
11.3.5.Others
11.4.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.Biotech Companies
11.4.2.Pharmaceutical Companies
11.4.3.Research Institutes
11.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
11.5.6.Rest of EU
12.Asia Pacific (APAC) Pharmaceutical Excipients Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Inorganic Chemicals
12.1.2.Organic Chemicals
12.1.3.Petrochemicals
12.2.  Function Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Fillers and Diluents
12.2.2.Coatings
12.2.3.Binders
12.2.4.Disintegrants
12.2.5.Flavouring Agents
12.2.6.Colorants
12.2.7.Others
12.3.  Dosage Form Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Tablets
12.3.2.Capsules
12.3.3.Liquids
12.3.4.Injections
12.3.5.Others
12.4.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.Biotech Companies
12.4.2.Pharmaceutical Companies
12.4.3.Research Institutes
12.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13.Middle East and Africa (MEA) Pharmaceutical Excipients Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
13.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Inorganic Chemicals
13.1.2.Organic Chemicals
13.1.3.Petrochemicals
13.2.  Function Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Fillers and Diluents
13.2.2.Coatings
13.2.3.Binders
13.2.4.Disintegrants
13.2.5.Flavouring Agents
13.2.6.Colorants
13.2.7.Others
13.3.  Dosage Form Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Tablets
13.3.2.Capsules
13.3.3.Liquids
13.3.4.Injections
13.3.5.Others
13.4.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Biotech Companies
13.4.2.Pharmaceutical Companies
13.4.3.Research Institutes
13.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14.Latin America Pharmaceutical Excipients Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
14.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Inorganic Chemicals
14.1.2.Organic Chemicals
14.1.3.Petrochemicals
14.2.  Function Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Fillers and Diluents
14.2.2.Coatings
14.2.3.Binders
14.2.4.Disintegrants
14.2.5.Flavouring Agents
14.2.6.Colorants
14.2.7.Others
14.3.  Dosage Form Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Tablets
14.3.2.Capsules
14.3.3.Liquids
14.3.4.Injections
14.3.5.Others
14.4.  End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.Biotech Companies
14.4.2.Pharmaceutical Companies
14.4.3.Research Institutes
14.5.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Ashland Inc.(U.S)
15.2.2.AkzoNobel (Netherlands)
15.2.3.The DOW Chemical Company (U.S)
15.2.4.Archer Daniels Midland Company(U.S)
15.2.5.Associated British Foods PLC (UK)
15.2.6.Colorcon, Inc.(U.S)
15.2.7.BASF SE(Germany)
15.2.8.Evonik Industries AG (Germany)
15.2.9.Innophos Holdings Inc. (U.S)
15.2.10.J.M. Huber Corporation (U.S)
15.2.11.FMC Corporation (U.S)
15.2.12.Roquette Group (Nord-Pas de Calais)
15.2.13.Croda International PLC (UK)
15.2.14.Merck KGaA (U.S)
15.2.15.Lubrizol Corporation (U.S)
16. Research Methodology 
17. Appendix and Abbreviations 
  • Ashland Inc.(U.S)
  • AkzoNobel (Netherlands)
  • The DOW Chemical Company (U.S)
  • Archer Daniels Midland Company(U.S)
  • Associated British Foods PLC (UK)
  • Colorcon, Inc.(U.S)
  • BASF SE(Germany)
  • Evonik Industries AG (Germany)
  • Innophos Holdings Inc. (U.S)
  • J.M. Huber Corporation (U.S)
  • FMC Corporation (U.S)
  • Roquette Group (Nord-Pas de Calais)
  • Croda International PLC (UK)
  • Merck KGaA (U.S)
  • Lubrizol Corporation (U.S)

Adjacent Markets